UBS Group AG - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTU and the CUSIP is G1125A124. A total of 35 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$2,106
+5.3%
2100.0%0.00%
Q3 2022$2,0000.0%2100.0%0.00%
Q2 2022$2,000
-71.4%
210
-68.9%
0.00%
Q1 2022$7,000
+40.0%
675
+38.3%
0.00%
Q4 2021$5,000
-16.7%
488
-14.1%
0.00%
Q3 2021$6,000
-66.7%
568
-68.8%
0.00%
Q2 2021$18,000
-25.0%
1,823
-24.4%
0.00%
Q1 2021$24,0002,4110.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q3 2021
NameSharesValueWeighting ↓
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 22,034$218,0000.03%
Westchester Capital Management, LLC 50,000$494,0000.01%
Walleye Capital LLC 37,192$369,0000.01%
SkyView Investment Advisors, LLC 3,183$31,0000.01%
HRT FINANCIAL LP 89,754$889,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 45,000$446,0000.00%
JANUS HENDERSON GROUP PLC 41,715$413,0000.00%
UBS Group AG 675$7,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 1,028$10,0000.00%
View complete list of BIOTECH ACQUISITION COMPANY shareholders